US Stock MarketDetailed Quotes

ADIL Adial Pharmaceuticals

Watchlist
  • 1.1100
  • -0.0200-1.77%
Close Jul 15 16:00 ET
  • 1.0800
  • -0.0300-2.70%
Post 19:04 ET
4.70MMarket Cap-365P/E (TTM)

About Adial Pharmaceuticals Company

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Company Profile

SymbolADIL
Company NameAdial Pharmaceuticals
Listing DateJul 27, 2018
Founded2010
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4870 Sadler Road,Suite 300
CityGlen Allen
ProvinceVirginia
CountryUnited States of America
Zip Code23060
Phone1-434-487-8196

Company Executives

  • Name
  • Position
  • Salary
  • Cary J Claiborne
  • Director, President and Chief Executive Officer
  • 1.02M
  • Joseph Truluck, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
  • 442.62K
  • Tony Goodman
  • Director and Chief Operating Officer
  • 124.17K
  • Kevin Schuyler, C.F.A.,M.B.A.
  • Chairman of the Board and Lead Independent Director
  • 108.17K
  • Robertson H. Gilliland, M.B.A.
  • Independent Director
  • 100.17K
  • James W. Newman, Jr
  • Independent Director
  • 106.17K
  • J. Kermit Anderson
  • Independent Director
  • 103.17K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg